Oncogenic Signalling through Mechanistic Target of Rapamycin (mTOR): A Driver of Metabolic Transformation and Cancer Progression.
about
mTOR Signaling and Neural Stem Cells: The Tuberous Sclerosis Complex Model.PI3K/Akt/mTOR Signaling Pathway and the Biphasic Effect of Arsenic in Carcinogenesis.Mechanistic Target of Rapamycin (mTOR) in the Cancer Setting.Therapeutic Targeting of mTOR in T-Cell Acute Lymphoblastic Leukemia: An Update
P2860
Oncogenic Signalling through Mechanistic Target of Rapamycin (mTOR): A Driver of Metabolic Transformation and Cancer Progression.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Oncogenic Signalling through M ...... mation and Cancer Progression.
@en
Oncogenic Signalling through Mechanistic Target of Rapamycin
@nl
type
label
Oncogenic Signalling through M ...... mation and Cancer Progression.
@en
Oncogenic Signalling through Mechanistic Target of Rapamycin
@nl
prefLabel
Oncogenic Signalling through M ...... mation and Cancer Progression.
@en
Oncogenic Signalling through Mechanistic Target of Rapamycin
@nl
P2860
P356
P1433
P1476
Oncogenic Signalling through M ...... mation and Cancer Progression.
@en
P2093
James T Murray
P2860
P356
10.3390/CANCERS10010005
P577
2018-01-03T00:00:00Z